Top picks in English

Veloxis Chairman wanted a commercial profile

According to Veloxis’ Chairman of the Board, Mette Kirstine Agger, Bill Polvino was not fired as CEO; the company simply needed to make a change to build the foundation for its commercial efforts in the US.
BY STEFAN SINGH KAILAY

Veloxis’ management group simply needed more commercial strength to get US sales of its drug product Envarsus up and running. That was the relatively simple conclusion the company’s Board of Directors had reached and the reason why it said last week that CEO Bill Polvino would resign with immediate effect to make way for Craig Collard, says Chairman Mette Kirstine Agger.

Allerede abonnent?Log ind her

Læs hele artiklen

Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

Med din prøveperiode får du:

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
    • Skal indeholde mindst 8 tegn samt tre af disse: Store bogstaver, små bogstaver, tal, symboler
    Skal indeholde mindst 2 tegn
    Skal indeholde mindst 2 tegn

    Få fuld adgang til dig og dine kollegaer

    Start et gratis virksomhedsprøveabonnement

    Del artikel

    Relaterede artikler

    Tilmeld dig vores nyhedsbrev

    Vær på forkant med udviklingen. Få den nyeste viden fra branchen med vores nyhedsbrev.

    Nyhedsbrevsvilkår

    Forsiden lige nu

    Læs også

    Job